跳至主要内容
临床试验/JPRN-UMIN000006398
JPRN-UMIN000006398已完成2 期

Clinical pharmacological trial of TM8001 for schizophrenia associated with carbonyl stress - Clinical pharmacological trial of TM8001 for schizophrenia associated with carbonyl stress

Tokyo Metropolitan Matsuzawa Hospital0 个研究点目标入组 10 人开始时间: 2011年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • creatinin >2mg/dL or BUN > 25mg/dL. HbA1c > 6.1% and fetal blood suger > 126mg/dL or blood suger > 200mg/dL. AST, ALT over 2.5 fold of standard level. Total bilirubin > 3mg/dL. sever cardiac diseases, lung diseases, hepatic diseases, neurological diseases, hematological diseases, endocrine diseases,immune diseases, other sever diseases. History of anaphylaxis shock, drug allergy. History of taking aminophylline , teophylline, cholinteophylline, levodopa within 4 weeks before trail. History of taking ECT within 3 months before trail. Possible risk of suicide. History of cancer within 5 years before trail. Participating other trial. Pregnancy. Inappropriate regarded by the responsible doctor.

研究者

相似试验